Circulating endothelial progenitor cells exhibit diurnal variation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 28, Issue 3, 2008, Pages

  Thomas, Honey E ^a   Redgrave, Rachael ^a   Cunnington, Michael S ^a   Avery, Peter ^a   Keavney, Bernard D ^a   Arthur, Helen M ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIBODY; CD45 ANTIGEN; CELL SURFACE MARKER; COLONY STIMULATING FACTOR; EDETIC ACID; VASCULOTROPIN RECEPTOR 2; BIOLOGICAL MARKER; CD34 ANTIGEN;

ADULT; BLOOD SAMPLING; BLOOD VOLUME; BONE MARROW CELL; CARDIOVASCULAR RISK; CELL COUNT; CIRCADIAN RHYTHM; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FLUORESCENT ANTIBODY TECHNIQUE; HEMATOPOIETIC SYSTEM; HUMAN; LETTER; MALE; NORMAL HUMAN; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; STEM CELL; ANALYSIS OF VARIANCE; BLOOD; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CYTOLOGY; MIDDLE AGED; MYELOID PROGENITOR CELL; PHYSIOLOGY; PREDICTION AND FORECASTING; PROBABILITY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

ADULT; ANALYSIS OF VARIANCE; ANTIGENS, CD34; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CIRCADIAN RHYTHM; COHORT STUDIES; CONFIDENCE INTERVALS; ENDOTHELIAL CELLS; HUMANS; MALE; MIDDLE AGED; MYELOID PROGENITOR CELLS; PREDICTIVE VALUE OF TESTS; PROBABILITY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 40749148944     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.107.160317     Document Type: Letter

References (19)

1. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res. 2004;95:343-353.
2. Shantsila E, Watson T, Lip GY. Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol. 2007;49:741-752.
3. Bonello L, Basire A, Sabatier F, Paganelli F, Dignat-George F. Endothelial injury induced by coronary angioplasty triggers mobilization of endothelial progenitor cells in patients with stable coronary artery disease. J Thromb Haemost. 2006;4:979-981.
4. Banerjee S, Brilakis E, Zhang S, Roesle M, Lindsey J, Philips B, Blewett CG, Terada LS. Endothelial progenitor cell mobilization after percutaneous coronary intervention. Atherosclerosis. 2006;189:70-75.
5. Gill M, Dias S, Hattori K, Rivera ML, Hicklin D, Witte L, Girardi L, Yurt R, Himel H, Rafii S. Vascular trauma induces rapid but transient mobilization of VEGFR2( + )AC133( + ) endothelial precursor cells. Circ Res. 2001;88:167-174.
6. Roberts N, Xiao Q, Weir G, Xu Q, Jahangiri M. Endothelial progenitor cells are mobilized after cardiac surgery. Ann Thorac Surg. 2007;83: 598-605.
7. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G. Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes. N Engl J Med. 2005;353:999-1007.
8. Schmidt-Lucke C, Rossig L, Fichtlscherer S, Vasa M, Britten M, Kamper U, Dimmeler S, Zeiher AM. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation. 2005;111:2981-2987.
9. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest. 2002;109:337-346.
10. Friedrich EB, Walenta K, Scharlau J, Nickenig G, Werner N. CD34-/ CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res. 2006;98:e20-25.
11. Laerum OD. Hematopoiesis occurs in rhythms. Exp Hematol. 1995;23: 1145-1147.
12. de Groot K, Bahlmann FH, Sowa J, Koenig J, Menne J, Haller H, Fliser D. Uremia causes endothelial progenitor cell deficiency. Kidney International. 2004;66:641-646.
13. Valgimigli M, Rigolin GM, Fucili A, Porta MD, Soukhomovskaia O, Malagutti P, Bugli AM, Bragotti LZ, Francolini G, Mauro E, Castoldi G, Ferrari R. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation. 2004;110: 1209-1212.
14. Haus E, Lakatua DJ, Swoyer J, Sackett-Lundeen L. Chronobiology in hematology and immunology. Am J Anat. 1983;168:467-517.
15. Born J, Lange T, Hansen K, Molle M, Fehm HL. Effects of sleep and circadian rhythm on human circulating immune cells. J Immunol. 1997; 158:4454-4464.
16. Dincol D, Akbulut H, Buyukcelik A, Icli F. Diurnal variations of serum GM-CSF levels. Cytokine. 2000;12:1151-1155.
17. Takeuchi M, Tanimoto Y, Tada A, Soda R, Takahashi K. Circadian rhythm of plasma levels of endogenous granulocyte colony stimulating factor in healthy volunteers. Int J Hematol. 1996;64:293-295.
18. Muller JE. Circadian variation in cardiovascular events. Am J Hypertens. 1999;12:35S-42S.
19. Peters RW, Zoble RG, Liebson PR, Pawitan Y, Brooks MM, Proschan M. Identification of a secondary peak in myocardial infarction onset 11 to 12 hours after awakening: the Cardiac Arrhythmia Suppression Trial (CAST) experience. J Am Coll Cardiol. 1993;22:998-1003.